Company Analysis HOOKIPA Pharma Inc.
1. Summary
Advantages
- Price (1.22 $) is less than fair price (4.86 $)
Disadvantages
- Dividends (0%) are below the sector average (0.5467%).
- The stock's return over the last year (-83.13%) is lower than the sector average (-25.51%).
- Current debt level 1.06% has increased over 5 years from 0.8515%.
- The company's current efficiency (ROE=-61.68%) is lower than the sector average (ROE=9.01%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| HOOKIPA Pharma Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -0.4% | -20.9% | -1.4% |
| 90 days | -35.9% | -25.3% | -9.2% |
| 1 year | -83.1% | -25.5% | 8.6% |
HOOK vs Sector: HOOKIPA Pharma Inc. has significantly underperformed the "Healthcare" sector by -57.62% over the past year.
HOOK vs Market: HOOKIPA Pharma Inc. has significantly underperformed the market by -91.71% over the past year.
Stable price: HOOK is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: HOOK with weekly volatility of -1.6% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (1.22 $) is lower than the fair price (4.86 $).
Price significantly below the fair price: The current price (1.22 $) is 298.4% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (57.09).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (48.45).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.4921) is lower than that of the sector as a whole (4.61).
P/BV vs Market: The company's P/BV (0.4921) is lower than that of the market as a whole (3.38).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.5735) is lower than that of the sector as a whole (33.5).
P/S vs Market: The company's P/S indicator (0.5735) is lower than that of the market as a whole (10.23).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (0.2644) is higher than that of the sector as a whole (-19.46).
EV/Ebitda vs Market: The company's EV/Ebitda (0.2644) is lower than that of the market as a whole (15.44).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -0.2259% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-0.2259%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (38.84%).
5.4. ROE
ROE vs Sector: The company's ROE (-61.68%) is lower than that of the sector as a whole (9.01%).
ROE vs Market: The company's ROE (-61.68%) is lower than that of the market as a whole (8.97%).
5.5. ROA
ROA vs Sector: The company's ROA (-35.68%) is lower than that of the sector as a whole (0.0151%).
ROA vs Market: The company's ROA (-35.68%) is lower than that of the market as a whole (6.3%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (-49.2%) is lower than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (-49.2%) is lower than that of the market as a whole (10.96%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5467%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
